Business
Alcon Introduces Clareon PanOptix Pro in Canada, Delivering the Lowest Light Scatter of any Trifocal IOL
TORONTO, June 20, 2025--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOptix® Pro intraocular lens (IOL) for cataract patients in Canada. PanOptix Pro leverages proprietary ENLIGHTEN® NXT Optical technology which delivers the lowest light scatter and highest reported light utilization of any trifocal IOL.1-3,5-9,**,‡‡ PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretic
About this update from Alcon Ag
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":250,"url":"https://media.zenfs.com/en/business-wire.com/d4f92e465106650b82cb3c56c3d2660e"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/6kg679G5MPd6_n2hdRfM2A--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTUwMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/d4f92e465106650b82cb3c56c3d2660e","width":480,"height":250}},"lazy":false},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":373,"height":480,"url":"https://media.zenfs.com/en/business-wire.com/ab98122112a528c151efca425bdd6737"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/3Yy0ZSRQm7Lgr7saELa1Jw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTkwNztjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/ab98122112a528c151efca425bdd6737","width":373,"height":480}}},{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":200,"url":"https://media.zenfs.com/en/business-wire.com/e17de129065bb65141cb6513eb4d721f"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/UGu7W2byTFqZ6ny7Eq8sIg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQwMDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/e17de129065bb65141cb6513eb4d721f","width":480,"height":200}}},{"type":"list","items":[{"val":[{"type":"text","content":"Clareon PanOptix Pro has half the light scatter of Clareon PanOptix1-3,*,**","length":75,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"PanOptix Pro provides an unprecedented 94% light utilization, compared to a theoretical maximum utilization of 96% for diffractive optics1-4,*,**,†","length":147,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Clareon PanOptix Pro provides more uninterrupted light distribution across the full visual range, and is designed for better image contrast1,††,‡","length":145,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":367,"olType":false},{"type":"text","content":"TORONTO, June 20, 2025--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced the approval of Clareon® PanOpt...